In listening to last CC CEO stated that enrollment is accelerating & at 28 sites looking for 3 to 4 tests a week per site. If this ramp up is defined in upcoming call & #'s come in at 250+ per month s/b a share price mover imo....Either way at these price levels sitting near cash on hand & FDA news months away is a great low risk / high reward setup I like ..... GLTA & make $$$$$$$$$$$$$$$$$$$$$$$
If they have already around 900 to 1000 they are on Schedule.
If they reach 1200 in the of august, that will more tan good!
I think only on the CC we will know, thats why is important the earnings...not the money because they have, but a new update about the enrollement and how fast they are doing that.